« Back to Inflammatory Disorders

Vesiculobullous Disorders

»What is the difference between a vesicle and a bulla?
»How are the bullous diseases defined?
»What things cause vesicles and bullae?
»How do you approach a patient who presents with an acute onset of a vesiculobullous eruption?
»Which skin findings are helpful in evaluating a patient with blisters?
»Do particular vesiculobullous diseases occur in characteristic distributions?
»Which tests are most useful in evaluating vesiculobullous diseases?
»How should a skin biopsy of a vesiculobullous eruption be performed?
»When are special tests necessary to diagnose blistering diseases of the skin?
»How are specimens obtained for direct immunofluorescence?
»For which vesiculobullous diseases are indirect immunofluorescence helpful?
»List the most common blistering diseases due to external agents.
»Name examples of drugs that can cause vesiculobullous eruptions.
»What is epidermolysis bullosa?
»Describe the other genetic blistering diseases.
»List the vesiculobullous diseases caused by metabolic disorders.
»Describe the clinical findings in bullous diabeticorum.
»What is the cause of pellagra?
»What is the difference between porphyria cutanea tarda and pseudoporphyria?
»What are the necrolytic erythemas?
»What is the difference between bullous pemphigoid and cicatricial pemphigoid?
»How do pemphigus vulgaris and pemphigus foliaceus differ?
»Linear IgA bullous dermatosis occurs in two different clinical situations. What are they?
»Describe the clinical findings in dermatitis herpetiformis.
»Does herpes gestationis have anything to do with herpes viruses?
»What is bullous systemic lupus erythematosus?
»What is epidermolysis bullosa acquisita?

 
 
 

For which vesiculobullous diseases are indirect immunofluorescence helpful?

It is most commonly used in pemphigus vulgaris (less commonly in bullous pemphigoid), epidermolysis bullosa acquisita, and cicatricial pemphigoid. This procedure identifies antibodies present in the circulation; therefore, serum is submitted for evaluation. It is most commonly used to obtain an antibody titer to help monitor disease activity. Again, only a few laboratories perform this testing routinely, so consultation with the laboratory prior to obtaining the specimen is recommended to ensure appropriate handling of the specimen. Enzyme-linked immunosorbent assay (ELISA) testing for these same serum antibodies has now become commercially available and is both sensitive and specific. ELISA has largely replaced indirect immunofluorescent studies as the study of choice for antibody titers and for detecting certain antibodies such as BP180, BP230, desmoglein 1, and desmoglein 3 in blistering diseases.